Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Nanomedicine (London, England)|January 9, 2023
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapyRiham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, et al.
Arab Journal of Urology|November 19, 2015
Evaluation of transvaginal slings using different materials in the management of female stress urinary incontinenceMohamed Teleb, Emad A Salem, Mohamed Naguib, et al.
Chemmedchem|September 21, 2021
Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular CarcinomaHosam H Khalil, Heba A Osman, Mohamed Teleb, et al.
ACS Omega|June 27, 2022
Harnessing ROS-Induced Oxidative Stress for Halting Colorectal Cancer via Thiazolidinedione-Based SOD InhibitorsMohamed Nabil Abd Al Moaty, El Sayed H El Ashry, Laila Fathy Awad, et al.
Bioorganic & Medicinal Chemistry|February 25, 2017
Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory painMohamed Teleb, Fang-Xiong Zhang, Junting Huang, et al.
ACS Omega|February 13, 2023
Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic OutcomesTasneem A Nasser, Rawan Adel, Abdelrahman Badr, et al.
Bioorganic Chemistry|February 17, 2024
The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapyMarwa M Shaaban, Mohamed Teleb, Hanan M Ragab, et al.
Colloids and Surfaces. B, Biointerfaces|February 6, 2020
Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapyOmnia M Ali, Adnan A Bekhit, Sherine N Khattab, et al.
European Journal of Medicinal Chemistry|March 26, 2023
Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potentialMohammed Salah Ayoup, Mariam M ElShafey, Hamida Abdel-Hamid, et al.
Bioorganic Chemistry|February 8, 2020
Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacologyEl Sayed Helmy El Ashry, Laila Fathy Awad, Mohamed Teleb, et al.
Pageof 12